Evidence map›Paper›PMID 34500862›Full record

ArticleMaterials (Basel, Switzerland)2021

Degradation and Characterisation of Electrospun Polycaprolactone (PCL) and Poly(lactic-co-glycolic acid) (PLGA) Scaffolds for Vascular Tissue Engineering.

Morteza Bazgir, Wei Zhang, Ximu Zhang, Jacobo Elies, Morvarid Saeinasab, Phil Coates, Mansour Youseffi, Farshid Sefat

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Electrospun Fibers EncapsulatingMolecules (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Morteza BazgirDepartment of Biomedical and Electronics Engineering, School of Engineering, University of Bradford, Bradford BD7 1DP, UK.
Wei ZhangState Key Laboratory of Polymer Materials Engineering, Polymer Research Institute, Sichuan University, Chengdu 610065, China.ORCID 0000-0001-5778-9936
Ximu ZhangChongqing Key Laboratory of Oral Disease and Biomedical Sciences and Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing 401174, China.
Jacobo EliesFaculty of Life Sciences, School of Pharmacy and Medical Sciences, University of Bradford, Bradford BD7 1DP, UK.ORCID 0000-0002-2518-8412
Morvarid SaeinasabDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.
Phil CoatesInterdisciplinary Research Centre in Polymer Science and Technology (Polymer IRC), University of Bradford, Bradford BD7 1DP, UK.
Mansour YouseffiDepartment of Biomedical and Electronics Engineering, School of Engineering, University of Bradford, Bradford BD7 1DP, UK.ORCID 0000-0002-4639-1313
Farshid SefatDepartment of Biomedical and Electronics Engineering, School of Engineering, University of Bradford, Bradford BD7 1DP, UK.ORCID 0000-0002-0911-5213
University of Bradford · GBFerdowsi University of Mashhad · IRSichuan University · CNStomatological Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study aimed to evaluate the characteristics and the effects of degradation on the structural properties of Poly(lactic-co-glycolic acid) (PLGA)- and polycaprolactone (PCL)-based nanofibrous scaffolds. Six scaffolds were prepared by electrospinning, three with PCL 15% (

Indexed as

degradationelectrospinningpolycaprolactone (PCL)Poly(lactic-co-glycolic acid) (PLGA)porous biodegradable membranetensile testtissue engineering

Identifiers

PMID34500862
PMCPMC8432541
OpenAlexW3194110622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.